⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIIB News
Biogen Inc. Common Stock
New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress
prnewswire.com
BIOA
BIIB
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026
globenewswire.com
BIIB
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026
prnewswire.com
BIIB
Securities Litigation on Behalf of Purchasers of Biogen, Inc. Securities (BIIB) Certified as Class Action
globenewswire.com
BIIB
Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting
globenewswire.com
BIIB
Semafor Unveils 450 Top Global CEOs and Government Leaders for Semafor World Economy 2026
prnewswire.com
HON
LLY
LAZ
QCOM
GS
BAH
BKR
PNC
ALL
MET
EXPE
JLL
MSFT
GOOG
NVDA
META
CRWD
VZ
BEN
CAVA
IBM
AMZN
INTC
AMD
CSCO
PANW
ETSY
UBER
LYFT
GE
USFD
SBUX
MCD
YUM
CVS
MRNA
PFE
JNJ
ABBV
BMY
GILD
REGN
AMGN
BIIB
VRTX
AZN
NVO
LULU
URBN
RL
MAT
UAA
INFY
ARM
ISRG
TDOC
TAP
FSLR
NEE
BE
PLUG
FCEL
RUN
SEDG
ENPH
ALNY
CRSP
EDIT
NTLA
ACLS
EXAS
ASO
ATHM
COIN
PYPL
MPWR
ON
AMAT
LRCX
KLAC
ASML
ADI
NXPI
TXN
WIT
HPE
OKTA
FTNT
DDOG
SNOW
PLTR
SPCE
RBLX
Sorcero Introduces Field Medical Excellence & Insights and Congress Intelligence Solutions to Accelerate Evidence-based Medical Affairs Strategies
prnewswire.com
AMGN
BIIB
ARGX
Saphnelo Surpasses Benlysta in CLE as Physicians Expand Use of Biologics Ahead of Key 2027 Catalysts
globenewswire.com
AZN
GSK
BIIB
GLP-1 Receptor Agonist Market to Hit USD 78.4 Billion by 2032, Growing at a CAGR of 3.66% with Rising Demand for Metabolic Disease Therapies | MarkNtel Advisors
prnewswire.com
LLY
BIIB
Recludix Pharma Promotes Executive Leaders Following Recent Corporate Accomplishments
globenewswire.com
AMGN
BIIB
MRK
SNY